Zhen Jane Wang

Zhen Jane Wang at UCSF is an expert in quantitative MRI and CT imaging biomarkers applied to abdominal malignancies including hepatocellular carcinoma and colorectal liver metastases. Her research has developed and validated radiomic features from MRI as biomarkers for treatment response prediction and tumor characterization. She has contributed to QIBA (Quantitative Imaging Biomarker Alliance) standards for imaging biomarker qualification. Her work addresses the practical implementation of imaging biomarkers in multicenter oncology trials.